David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Prospect Capital
PSEC
$1.2B
| $745K | ﹤0.01% |
+124,437
| New | +$717K |
|
|
MARX
3177
DELISTED
Mars Acquisition Corp. Ordinary Shares
MARX
| $744K | ﹤0.01% |
70,000
| – | – |
|
3178
Insulet
PODD
$9.92B
| $742K | ﹤0.01% |
3,419
-5,938
| -63% | -$1.02M |
|
|
AEVA
3179
Aeva Technologies
AEVA
$1.13B
| $742K | ﹤0.01% |
195,787
+44,339
| +29% | +$142K |
|
3180
PUT
ZIM Integrated Shipping Services
ZIM
$3.38B
| $740K | ﹤0.01% |
+75,000
| New | +$630K |
|
|
EXAS
3181
CALL
DELISTED
Exact Sciences
EXAS
| $740K | ﹤0.01% |
10,000
| – | – |
|
3182
Trinity Capital Inc
TRIN
$1.77B
| $738K | ﹤0.01% |
+50,816
| New | +$731K |
|
3183
Absci
ABSI
$1.65B
| $738K | ﹤0.01% |
+175,740
| New | +$326K |
|
3184
PUT
UGI
UGI
$8.23B
| $738K | ﹤0.01% |
30,000
-60,000
| -67% | -$1.32M |
|
3185
PUT
Bumble
BMBL
$375M
| $737K | ﹤0.01% |
50,000
-202,000
| -80% | -$2.87M |
|
|
NUVL
3186
CALL
DELISTED
Nuvalent
NUVL
| $736K | ﹤0.01% |
+10,000
| New | +$619K |
|
3187
Seer Inc
SEER
$113M
| $735K | ﹤0.01% |
379,100
+164,018
| +76% | +$292K |
|
|
SCWX
3188
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $733K | ﹤0.01% |
99,312
-15,630
| -14% | -$94K |
|
3189
Hope Bancorp
HOPE
$1.77B
| $733K | ﹤0.01% |
60,663
-123,597
| -67% | -$1.23M |
|
3190
Acco Brands
ACCO
$389M
| $732K | ﹤0.01% |
120,432
-52,681
| -30% | -$279K |
|
3191
Axsome Therapeutics
AXSM
$10.8B
| $731K | ﹤0.01% |
+9,184
| New | +$614K |
|
3192
Vanguard Morningstar Growth ETF
VUG
$225B
| $730K | ﹤0.01% |
+14,088
| New | +$680K |
|
3193
Kadant
KAI
$3.58B
| $729K | ﹤0.01% |
2,601
-6,109
| -70% | -$1.53M |
|
|
PPL
3194
PPL Corp
PPL
$26.3B
| $727K | ﹤0.01% |
26,841
-3,082
| -10% | -$78.2K |
|
3195
MSC Industrial Direct
MSM
$6.61B
| $726K | ﹤0.01% |
7,173
-3,830
| -35% | -$379K |
|
|
ROIC
3196
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $724K | ﹤0.01% |
51,636
-213,030
| -80% | -$2.68M |
|
3197
Peapack-Gladstone Financial
PGC
$800M
| $724K | ﹤0.01% |
24,280
-1,871
| -7% | -$48.7K |
|
3198
GrafTech
EAF
$175M
| $721K | ﹤0.01% |
32,926
+8,715
| +36% | +$246K |
|
3199
California Resources
CRC
$4.59B
| $720K | ﹤0.01% |
13,175
-22,039
| -63% | -$1.16M |
|
3200
Sunstone Hotel Investors
SHO
$2.11B
| $719K | ﹤0.01% |
67,007
-181,464
| -73% | -$1.79M |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.